Neogenomics Inc (NASDAQ:NEO)

13.92
Delayed Data
As of Jun 21
 +0.45 / +3.34%
Today’s Change
7.08
Today|||52-Week Range
14.04
+57.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues66.1M63.1M67.8M63.4M
 
 
 
 
 
Cost of Goods Sold31.0M30.4M30.8M32.5M
 
 
 
 
 
Depreciation And Amortization5.6M5.5M5.7M5.0M
 
 
 
 
 
 
Operating ExpensesGross Income29.5M27.1M31.3M25.9M
 
 
 
 
 
General Expenses28.2M29.4M26.9M23.4M
 
 
 
 
 
Research And Development947.0K1.3M556.0K956.0K
 
 
 
 
 
Total Operating Expenses64.8M65.4M63.3M60.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.3M-2.3M4.5M2.5M
 
 
 
 
 
Interest Expense On Debt1.4M1.4M1.4M1.5M
 
 
 
 
 
Other Expenses0.00-1.1M-264.0K63.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-97.0K-4.8M2.9M1.1M
 
 
 
 
 
Income Taxes-54.0K-340.0K-2.1M-438.0K
 
 
 
 
 
Preferred Dividend-2.6M-2.7M-2.7M-2.9M
 
 
 
 
 
Net Income-43.0K-5.1M5.0M644.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS79.4M79.6M86.7M80.5M
 
 
 
 
 
Shares To Calculate EPS Diluted79.4M79.6M88.6M80.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.10$0.03-$0.03
 
 
 
 
 
EPS Diluted-$0.03-$0.10$0.03-$0.03